Prof. David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. - University of Texas Southwestern Medical Center is  - Professor, Director and Dallas Foundation Chair in Gynecologic Oncology

Prof. David Scott Miller

M.D., F.A.C.O.G., F.A.C.S.

University of Texas Southwestern Medical Center is

Professor, Director and Dallas Foundation Chair in Gynecologic Oncology

Dallas, TX | United States

Main Specialties: Obstetrics & Gynecology, Oncology

Additional Specialties: Gynecologic Oncolgy

ORCID logohttps://orcid.org/0000-0002-8215-5887

Prof. David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. - University of Texas Southwestern Medical Center is  - Professor, Director and Dallas Foundation Chair in Gynecologic Oncology

Prof. David Scott Miller

M.D., F.A.C.O.G., F.A.C.S.

Introduction

David Scott Miller, M.D., F.A.C.O.G., F.A.C.S.,

Amy and Vernon E. Faulconer Distinguished Chair in Medical Science,

Director and Dallas Foundation Chair in Gynecologic Oncology,

Professor of Obstetrics & Gynecology,

Fred F. Florence Bioinformation Center, #E6.102M,

University of Texas Southwestern Medical Center,

5323 Harry Hines Blvd.,

Dallas, TX 75390-9032

Primary Affiliation: University of Texas Southwestern Medical Center is - Dallas, TX , United States

Specialties:

Additional Specialties:

Publications

24Publications

551Reads

55Profile Views

A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer.

Int J Radiat Oncol Biol Phys 2020 03 5;106(3):464-471. Epub 2019 Nov 5.

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Texas; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.10.042DOI Listing
March 2020
1 Read
4.258 Impact Factor

Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Gynecol Oncol 2020 Feb 13;156(2):423-429. Epub 2019 Dec 13.

Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.12.003DOI Listing
February 2020
5 Reads
3.774 Impact Factor

Second-line lenvatinib in patients with recurrent endometrial cancer.

Gynecol Oncol 2020 Jan 16. Epub 2020 Jan 16.

Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.12.039DOI Listing
January 2020
3.774 Impact Factor

Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?

Int J Gynecol Pathol 2019 Nov;38(6):533-542

Departments of Pathology (E.L., H.C., K.M., D.H.C., G.R.C., L.L., S.H., J.T., W.Z.) Obstetrics and Gynecology (J.L., D.S.M., W.Z.) Harold C. Simmons Comprehensive Cancer Center (E.L., D.H.C, J.L., D.S.M., W.Z.), UTSW Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000557DOI Listing
November 2019
2 Reads
1.631 Impact Factor

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.

N Engl J Med 2019 06;380(24):2317-2326

From Northwestern University (D. Matei) and Loyola University (W.S.) - both in Chicago; NRG Oncology Statistical and Data Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY (V.F., H.Q.H.); University of Kentucky, Lexington (M.E.R.); Washington University School of Medicine, Siteman Cancer Center, St. Louis (D. Mutch, M.A.P.); Women and Infants Hospital in Rhode Island-The Warren Alpert Medical School of Brown University, Providence (M.M.S., P.A.D.); Stephenson Cancer Center Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City (K.M.M.); Asan Medical Center, University of Ulsan, Songpa-gu, Seoul, South Korea (Y.M.K.); Ohio State University, Columbus (D.M.O.); Women's Cancer Center of Nevada, Las Vegas (N.M.S.); University of California Irvine Medical Center, Irvine (K.S.T.); Lewis Cancer and Research Pavilion at St. Joseph's-Candler, Savannah, GA (W.E.R.); Case Western Reserve University Hospital, Cleveland (J.N.); Dana-Farber Cancer Institute, Boston (U.A.M.); and the University of Texas Southwestern Medical Center, Dallas (D.S.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1813181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948006PMC
June 2019
17 Reads
55.873 Impact Factor

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Lancet Oncol 2019 May 1;20(5):636-648. Epub 2019 Apr 1.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St Joseph's Hospital, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30029-4DOI Listing
May 2019
10 Reads
24.690 Impact Factor

Reply to F. Tomao et al.

J Clin Oncol 2019 04 27;37(11):936. Epub 2019 Feb 27.

Martee L. Hensley, MD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Danielle Enserro, PhD, Roswell Park Comprehensive Cancer Center, Buffalo, NY; and David S. Miller, MD, The University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.02063
Publisher Site
http://dx.doi.org/10.1200/JCO.18.02063DOI Listing
April 2019
3 Reads
18.428 Impact Factor

The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience.

Am J Clin Oncol 2018 12;41(12):1225-1230

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000458DOI Listing
December 2018
39 Reads
2.611 Impact Factor

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.

J Clin Oncol 2018 Oct 5:JCO1800454. Epub 2018 Oct 5.

Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Martee L. Hensley and Oliver Zivanovic, Weill Cornell Medical College, New York City; Danielle Enserro and Shashikant B. Lele, Roswell Park Comprehensive Cancer Center, Buffalo, NY; Helen Hatcher, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge; Cyril Fisher, University of Birmingham, Birmingham, United Kingdom; Petronella B. Ottevanger, Radboud University Medical Center, Nijmegen, the Netherlands; Anders Krarup-Hansen, University Hospital Copenhagen, Copenhagen, Denmark; Jean-Yves Blay, Centre Leon Berard, Lyon, France; Katherine M. Moxley, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Jayanthi S. Lea, and David S. Miller, The University of Texas Southwestern Medical Center, Dallas, TX; Krishnansu S. Tewari, University of California at Irvine, Orange, CA; Premal H. Thaker, Washington University School of Medicine, and Siteman Cancer Center, St Louis, MO; David M. O'Malley, The Ohio State University College of Medicine, Columbus, OH; Katina Robison, Women and Infants Hospital in Rhode Island, Providence, RI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00454
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241678PMC
October 2018
24 Reads
18.428 Impact Factor

Third-line Salvage Chemotherapy for Recurrent Carcinoma of the Cervix is Associated With Minimal Response Rate and High Toxicity.

Am J Clin Oncol 2018 08;41(8):797-801

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000372DOI Listing
August 2018
7 Reads
2.611 Impact Factor

Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer.

J Surg Oncol 2018 Apr 6;117(5):1020-1028. Epub 2018 Feb 6.

The University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24990DOI Listing
April 2018
7 Reads
3.244 Impact Factor

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

Int J Cancer 2018 03 6;142(6):1102-1115. Epub 2017 Nov 6.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31127
Publisher Site
http://dx.doi.org/10.1002/ijc.31127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798245PMC
March 2018
4 Reads
5.085 Impact Factor

Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer.

Am J Clin Oncol 2018 Mar 8. Epub 2018 Mar 8.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000439DOI Listing
March 2018
27 Reads
2.611 Impact Factor

Chemo- and radiotherapy in adjuvant management of optimally debulked endometrial cancer.

J Natl Compr Canc Netw 2009 May;7(5):535-41

University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2009.0036DOI Listing
May 2009
4 Reads
4.178 Impact Factor

Localized retroperitoneal lymphangioleiomyomatosis mimicking malignancy. A case report and review of the literature.

Arch Pathol Lab Med 2003 Jul;127(7):879-82

Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75390-9073, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2003)127<879:LRLMM>2.0.CO;2DOI Listing
July 2003
11 Reads
2.838 Impact Factor

Top co-authors

Jayanthi S Lea
Jayanthi S Lea

University of Texas Southwestern Medical Center

8
Siobhan M Kehoe
Siobhan M Kehoe

University of Texas Southwestern

5
Debra L Richardson
Debra L Richardson

The Ohio State University College of Medicine

5
Dustin B Manders
Dustin B Manders

University of Texas Southwestern Medical Center

4
Marcus E Randall
Marcus E Randall

East Carolina University

3
Kevin Albuquerque
Kevin Albuquerque

Loyola University Health System

3
Jayanthi Lea
Jayanthi Lea

University of Texas Southwestern Medical Center

3
Paul A Disilvestro
Paul A Disilvestro

Massachusetts General Hospital

3
Nick M Spirtos
Nick M Spirtos

Women's Cancer Center

3
Danielle Enserro
Danielle Enserro

Boston University School of Public Health

3